Answer
Neuroleptic malignant syndrome reported with paliperidone is characterised by hyperthermia, muscle rigidity, autonomic instability, altered consciousness and elevated serum creatine phosphokinase levels, with possible additional signs of myoglobinuria (rhabdomyolysis) and acute renal failure.
Sources for this answer
- Invega 3 mg prolonged-release tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked